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Objectives This study investigates alterations in myocardial microvasculature, fibrosis, and hypertrophy before and after
mechanical unloading of the failing human heart.
Background Recent studies demonstrated the pathophysiologic importance and significant mechanistic links among micro-
vasculature, fibrosis, and hypertrophy during the cardiac remodeling process. The effect of left ventricular assist
device (LVAD) unloading on cardiac endothelium and microvasculature is unknown, and its influence on fibrosis
and hypertrophy regression to the point of atrophy is controversial.
Methods Hemodynamic data and left ventricular tissue were collected from patients with chronic heart failure at LVAD implant
and explant (n  15) and from normal donors (n  8). New advances in digital microscopy provided a unique oppor-
tunity for comprehensive whole-field, endocardium-to-epicardium evaluation for microvascular density, fibrosis, cardio-
myocyte size, and glycogen content. Ultrastructural assessment was done with electron microscopy.
Results Hemodynamic data revealed significant pressure unloading with LVAD. This was accompanied by a 33% in-
crease in microvascular density (p  0.001) and a 36% decrease in microvascular lumen area (p  0.028). We
also identified, in agreement with these findings, ultrastructural and immunohistochemical evidence of endothe-
lial cell activation. In addition, LVAD unloading significantly increased interstitial and total collagen content with-
out any associated structural, ultrastructural, or metabolic cardiomyocyte changes suggestive of hypertrophy
regression to the point of atrophy and degeneration.
Conclusions The LVAD unloading resulted in increased microvascular density accompanied by increased fibrosis and no evidence
of cardiomyocyte atrophy. These new insights into the effects of LVAD unloading on microvasculature and associated
key remodeling features might guide future studies of unloading-induced reverse remodeling of the failing human
heart. (J Am Coll Cardiol 2010;56:382–91) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.04.019t
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She number of patients who receive left ventricular assist
evices (LVAD) is rapidly increasing (1), which offers a
aluable opportunity for in-depth investigations into human
ardiac biology (2,3). The examination of paired human
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esearch Resources Public Health Services Research Grant UL1-RR025764; and the
epartment of Defense (to Dr. Li). Dr. Li is a Burroughs Wellcome Foundation Clinical
cientist in Translational Research and an Established Investigator of the American Heart
ssociation (AHA). A National Institutes of Health National Center for Research
esources Grant supports the Center for Clinical and Translational Science (UL1-
R025764 and C06-RR11234 to Drs. Kfoury and Drakos). Dr. Drakos was supported by
Hellenic Cardiological Society Grant 11.2006 for Molecular Cardiology Research. Dr
tehlik is supported by an AHA Grant #09CRP2050127. Drs. Kfoury and Drakos are
upported by a Deseret Foundation, Utah, Grant #571.
Manuscript received March 1, 2010, accepted April 5, 2010.
t
r
(
u
i
a
v
m
w
h
t
i
u
d
t
t
o
t
c
o
u
t
b
i
fi
p
d
f
i
r
t
c
p
v
p
m
M
S
u
C
p
r
i
f
n
u
C
g
s
w
w
H
m
c
o
a
t
t
s
1
i
s
T
c
(
P
d
t
a
a
d
b
t
s
W
c
f
i
e
r
M
S
g
r
t
c
M
s
C
c
a
b
fi
t
i
v
t
w
s
T
v
s
e
c
383JACC Vol. 56, No. 5, 2010 Drakos et al.
July 27, 2010:382–91 Unloading, Microvasculature, and Cardiac Remodelingion a precious “research vehicle” for investigating new
emodeling and regenerative therapies for heart failure
HF). Yet, for these promises to be fulfilled, we must first
nderstand the fundamental impact of mechanical unload-
ng on the failing human heart.
Pathophysiologic models derived from basic science and
nimal studies focus on the role of excess load in driving a
icious cycle of cardiac remodeling (4). This mechanistic
odel led to the hypothesis that mechanical unloading
ould disrupt this cycle and improve function of the failing
uman heart (2,3,5). Despite the opportunity afforded by
he use of LVAD in clinical practice, the effects of mechan-
cal unloading on basic remodeling features are still poorly
nderstood or unknown (2,3,5). It is noteworthy that the
irect effect of mechanical unloading on myocardial endo-
helium and microvasculature is unknown, and its effect on
he degree of hypertrophy regression, possibly to the point
f atrophy, is controversial (2,5). Furthermore, reports of
he LVAD unloading effects on cardiac fibrosis have been
onflicting, with some showing reduction in fibrosis, and
thers showing an increase (2,3,5,6). The need for further
nderstanding of the impact of unloading on specifically
hese key remodeling features is now even more acute,
ecause there is increasing robust evidence demonstrating
mportant mechanistic links among microvasculature,
brosis, and hypertrophy during the cardiac remodeling
rocess (7,8).
Here, we use whole field, endocardium-to-epicardium
igital microscopy (9,10) coupled with ultrastructural and
unctional evaluation to examine the influence of mechan-
cal unloading on these three central features of cardiac
emodeling. The application of state-of-the-art digital his-
opathology for examination of left ventricular (LV) myo-
ardial samples acquired from normal donors and from
atients with end-stage chronic HF markedly increases the
olume of tissue objectively and quantitatively analyzed and
rovides a new standard for future studies in the field of
echanical unloading and cardiac remodeling.
ethods
tudy population. The study group comprised 15 consec-
tive patients who received HeartMate I LVAD (Thoratec
orporation, Pleasanton, California) as a bridge to trans-
lantation due to chronic end-stage HF. Patients who
eceived LVAD support due to acute HF (n 11) were not
ncluded. Eight age-matched donors whose hearts were
ound to be functionally and structurally normal but were
ot suitable for transplantation for noncardiac reasons were
sed as normal control subjects.
linical data collection. We collected patient demo-
raphic data, data on comorbidities, echocardiography re-
ults, invasive hemodynamic data, and laboratory data
ithin 24 h before LVAD implantation and again between
eeks 2 and 4 after LVAD implantation. fiistochemical stains and im-
unohistochemistry. Myo-
ardial tissue was prospectively
btained from the LV apical core
t LVAD implantation. At the
ime of cardiac transplantation,
he tissue was obtained from the
urrounding apical area, at least
cm distant from the LVAD
nflow cannula (to avoid inclu-
ion of reactive tissue changes).
issue preparation and use of Masson’s trichrome stain for
ollagen content evaluation, periodic acid Schiff reaction
PAS) for cardiomyocyte size evaluation, the combination of
AS and periodic acid Schiff with diastase (PASD) for
emonstration of glycogen content, and immunostaining for
he endothelial cell protein CD34 and the endothelial
ctivation marker major histocompatibility complex class 2
re detailed in the Online Appendix. To achieve a high
egree of reproducibility we avoided manual staining, and
oth the histochemical stains and the immunohistochemis-
ry experiments were performed with automatic staining
ystems (Online Appendix).
hole-field digital microscopy. Advanced digital micros-
opy allowed examination of the entire heart tissue areas
rom the epicardium to the endocardium. Whole-slide
mages were analyzed with the ScanScope XT system
quipped with the ImageScope 10.0 image analysis algo-
ithms (Aperio Technologies, Vista, California) (9,10).
ICROVASCULATURE EVALUATION. We used the Image-
cope 10.0 Microvessels analysis algorithm (10) to distin-
uish endothelial cells from nonspecific staining of sur-
ounding tissue by applying appropriate dark and light
hresholds (Fig. 1). Only myocardial tissue cuts oriented in
ross section (epicardium to endocardium) were analyzed.
icrovascular density was defined as “number of microves-
els”/“total tissue analysis area.”
OLLAGEN CONTENT EVALUATION. We set the staining
olor threshold of the ImageScope 10.0 Colocalization
nalysis algorithm to accurately identify collagen on the
asis of its blue color (Figs. 2A and 2B). “Interstitial
brosis” was defined as the collagen content determined in
he interstitial spaces and endomysial/perimysial spaces,
ncluding the collagen content around capillaries and small
essels (i.e., vessels with diameter 60 m) found within
hose spaces. The “total” collagen content (“total fibrosis”)
as determined by including in our analysis the whole-field
tained tissue without excluding any areas (Figs. 2C to 2E).
he collagen content around medium and large vessels (i.e.,
essels with diameter 60 m), “perivascular fibrosis,” was
eparately calculated by subtracting the “interstitial/perimysial/
ndomysial” collagen content from the determined “total”
ollagen content (i.e., “total fibrosis” minus “interstitial
Abbreviations
and Acronyms
HF  heart failure
LV  left ventricular
LVAD  left ventricular
assist device
PAS  periodic acid Schiff
PASD  periodic acid
Schiff with diastasebrosis”).
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Unloading, Microvasculature, and Cardiac Remodeling July 27, 2010:382–91ARDIOMYOCYTE SIZE AND GLYCOGEN CONTENT EVALUATION.
ardiomyocytes were accepted for size measurement if they
et specific criteria detailed in the Online Appendix.
lycogen content was evaluated by adjusting the staining
olor thresholds of the algorithm to precisely capture the
agenta PAS-positive stain. To exclude nonglycogen, ma-
enta PAS-positive staining substances, a paired adjacent
lide was analyzed after glycogen depolymerization with the
ASD reaction (Online Appendix). Next, with our algo-
ithm, glycogen stores could be evaluated by digital subtrac-
ion of the images derived from 2 paired adjacent slides
tained with PAS and PASD each. Glycogen content was
efined as the percentage of magenta stained area for the
AS stained slide minus the PASD stained slide for
dentical regions of interest.
lectron microscopy studies. Tissue was examined ac-
ording to a classification scheme that was based on previous
ork in the field by our group (11) as well as according to
ur pre-specified research hypotheses for this study. The
nline Appendix section describes the specific parameters
ncluded in this ultrastructural classification scheme to
ssess microvasculature and cardiomyocyte hypertrophy,
egeneration, and atrophy.
tatistical analysis. An independent samples t test, a
aired t test, and a Wilcoxon signed rank test were used to
Figure 1 Microvasculature Evaluation
(A, B) Left ventricular mid-myocardium immunohistochemically stained for the end
adjusted to allow microvascular evaluation within selected regions of interest. (A)
microvessels by the analysis algorithm enables measurements like vessel perimetssess the statistical significance of differences observed. bOur Institutional Review Board approved the study, and
nformed consent was obtained from patients before their
nrollment.
esults
linical and hemodynamic data. Patient demographic
ata and clinical and hemodynamic characteristics are
hown in Table 1. Cardiac index and left and right sided
ressures virtually normalized during LVAD support re-
ealing significant LVAD-induced pressure unloading
Table 2). Medications used during LVAD support are
isted in the Online Appendix.
tructural, ultrastructural, and metabolic data. The total
issue area under examination included all of the myocardial
issue sectioned and mounted on the slides (Figs. 2D and 2E).
s such, the final average tissue analysis area/patient sample
as 74.9  49.5 mm2.
ICROVASCULATURE STUDIES. Microvascular density as
ssessed with digital microscopy was found to be signifi-
antly decreased in the failing hearts compared with the
ormal donor hearts. After LVAD unloading there was a
3% increase in microvascular density (p  0.001) (Fig. 3).
nloading effects on the microvasculature did not differ
l cell protein CD-34 (brown color). Algorithm thresholds were appropriately
agnification; (B) 60 magnification. (C) Automatic completion of stained
lumen area.othelia
20 m
er andetween ischemic and nonischemic chronic HF patients.
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July 27, 2010:382–91 Unloading, Microvasculature, and Cardiac RemodelingNext, we examined the ultrastructural effects of LVAD
nloading on microvasculature by electron microscopy stud-
es in a randomly selected subset of HF patients (n  5,
Figure 2 Collagen Content Evaluation
Sections were stained with Masson’s Trichrome stain—collagen stains blue. (A) R
formed. (B) The section was digitally analyzed for collagen content on the basis o
sufficiently sensitive and accurate to exclude even small nuclei (arrows) within the
mined in manually selected regions of interest that excluded bands of perivascula
sels). (D) Whole slide, epicardium-to-endocardium image showing superimposed a
criterion described in C (0.5 magnification). (E) “Total” collagen content (“total fi
without excluding any areas (0.5 magnification).
ndividual Patient CharacteristicsTable 1 Individual Patient Characteristics
Patient
#
Age (yrs)/
Sex
HF
Etiology DM
HR
(beats/min)
SBP
(mm Hg)
LVEF
(%)
RA
(mm Hg)
1 57/M IDC No 106 90 20 12
2 55/M IDC No 120 95 10 13
3 39/M IDC No 115 85 10 12
4 59/M IDC No 95 90 10 9
5 50/M IDC Yes 129 90 15 10
6 51/M IDC No 120 85 10 9
7 17/M IDC No 120 110 20 20
8 62/M ICM No 118 80 5 8
9 49/M ICM No 101 95 15 5
10 64/M ICM Yes 80 95 15 11
11 48/M ICM No 91 105 20 8
12 49/M ICM No 125 95 22 15
13 58/M ICM No 95 80 25 12
14 57/M ICM No 124 95 10 17
15 57/M ICM No 101 80 20 7
I cardiac index; Cr serum creatinine; DM diabetes mellitus; Hgb hemoglobin; HR hear
ssist device; LVEF left ventricular ejection fraction; Na serum sodium; PAs systolic pulmonary arte
A  right atrial pressure; SBP  systolic blood pressure; WU  Wood unit.atients #1, #2, #6, #8, and #14). We identified ultrastruc-
ural evidence of post-LVAD endothelial cell activation
pre-LVAD grading: 0.4  0.5 vs. post-LVAD: 1.8  1.0,
entative stained image from mid-myocardium before digital analysis was per-
thresholds. The analysis algorithm “highlighted” collagen as dark blue and was
s tissue. (C) “Interstitial fibrosis” was defined as the collagen content deter-
is associated with any vessel with diameter 60 m (i.e., medium/large ves-
egions selected for assessment of “interstitial fibrosis” on the basis of the
”) was determined by including in our analysis the whole-field stained tissue
ore LVAD Implantation
Duration
of Support
(days)
As
Hg)
PCWP
(mm Hg)
CI
(l/min/m2)
PVR
(WU)
Na
(mmol/l)
Cr
(mg %)
Hgb
(g/dl)
55 30 1.7 2.7 131 1.0 11.0 183
70 26 1.4 3.4 133 1.2 11.2 63
53 32 1.8 3.5 124 2.1 10.0 24
55 23 1.7 4.8 128 1.0 13.2 33
62 30 1.8 3.0 148 3.0 10.6 70
60 25 2.0 3.4 144 1.7 9.0 28
56 37 1.5 2.8 135 1.6 14.0 212
50 25 1.8 2.5 131 1.2 13.6 86
39 22 2.0 1.5 135 1.3 10.1 283
02 31 2.8 6.5 135 1.9 10.0 187
88 32 2.8 6.0 133 1.6 11.0 113
40 23 3.2 0.6 132 2.5 13.0 79
61 29 2.2 3.7 131 1.9 12.0 22
45 30 2.8 2.5 135 0.9 13.0 21
47 20 2.8 2.6 132 2.6 10.8 21
CM ischemic cardiomyopathy; IDC idiopathic dilated cardiomyopathy; LVAD left ventricularepres
f color
fibrou
r fibros
ll the r
brosisBef
P
(mm
1
t rate; I
ry pressure; PCWP pulmonary capillary wedge pressure; PVR pulmonary vascular resistance;
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Unloading, Microvasculature, and Cardiac Remodeling July 27, 2010:382–91 0.038), in agreement with the digital histopathology
ata revealing post-LVAD increase in microvascular den-
ity. The most striking of these post-LVAD changes were:
) basal lamina reduplication; 2) increase in the number of
umenal cytoplasmic processes and irregular surface mem-
rane projections; and 3) increased size of nuclei and
ncreased number of cytoplasm organelles protruding into
he capillary lumen, which significantly decreased the lume-
al area (Fig. 4) (12). In further agreement with these
ndings the post-LVAD expression of the endothelial
ctivation marker major histocompatibility complex class 2
as consistently found to be increased in all of our patient
amples (Online Appendix).
Because we discovered these specific ultrastructural mi-
rovasculature changes, we further proceeded with applica-
ion of the unique tools of digital microscopy at the
tructural level and estimated the average microvessel lume-
al area (defined as “total lumenal area measured in the
ntire tissue analysis area”/“number of microvessels mea-
ured in the entire tissue analysis area”). In agreement with
he ultrastructural findings, the average lumenal area was
ound to be decreased post-LVAD unloading by 36%
p  0.028) (Fig. 5). However, the fact that we had
oncomitantly found increased microvessel density after
VAD raised the possibility that, even if the average micro-
ascular lumenal area (i.e., lumenal area/microvessel) is de-
reased, the total microvessel lumenal area (i.e., the sum of the
umenal areas of all microvessels in the entire examined
yocardial area) might not be decreased. For this reason we
lso assessed the “total lumenal area measured in the entire
issue analysis area”/“entire tissue analysis area,” and this value
as found to be decreased by 18% after LVAD.
IBROSIS STUDIES. “Interstitial” and “total fibrosis” were
ignificantly increased in failing hearts compared with nor-
emodynamic Parametersfore and After LVAD UnloadingTable 2 Hemodynamic ParametersBefore and After LVAD Unloading
Before LVAD After LVAD p Value
Heart rate, beats/min 109 15 82 29 0.01
Systemic arterial blood
pressure, mm Hg
Systolic 91 9 115 21 0.001
Diastolic 55 8 63 13 0.04
Right atrial pressure, mm Hg 11.2 3.9 10.8 5.3 0.776
Mean pulmonary artery
pressure, mm Hg
41.9 10.4 22.3 4.4 0.001
Diastolic pulmonary artery
pressure, mm Hg
31.7 5.6 16.1 5.5 0.001
Pulmonary capillary wedge
pressure, mm Hg
27.7 4.7 10.8 4.4 0.001
Cardiac index, l/m2/min 2.1 0.6 2.9 0.3 0.001
Pulmonary vascular
resistance, Wood units
3.3 1.5 2.0 0.5 0.008
 15. Values are mean  SD.
LVAD  left ventricular assist device.al donor hearts and increased further after LVAD unload-ng by 61% (p  0.001) and 35% (p  0.001), respectively
Fig. 6). The fibrosis around medium and large vessels (i.e.,
perivascular fibrosis”) was found to be similar in pre- and
ost-LVAD samples. Therefore, the increase in “total
brosis” was driven exclusively by increase of “interstitial
brosis.” The effect on fibrosis was similar between the
schemic and the nonischemic chronic HF patients.
ARDIOMYOCYTE STUDIES. Cardiomyocyte size, as as-
essed by digital microscopy, decreased after unloading
pre-LVAD cardiomyocyte cross section area: 923  336
m2 vs. post-LVAD cross section area: 733  194 m2,
 0.027) but not beyond that of normal donor hearts
donor cross section area: 543  119 m2, p  0.009)—a
nding that might have suggested unloading induced atro-
hy (Fig. 7A). The results were similar for the subset of
atients that underwent prolonged duration (6 months) of
echanical unloading. Similarly, the comparison of the
ltrastructural electron microscopy findings of the normal
onor and pre-LVAD myocardial samples with the
ost-LVAD tissue revealed no evidence suggestive of
ypertrophy regression to the point of cardiomyocyte
egeneration and atrophy. Specifically, myofilament loss
1.0  0.8 vs. 1.0  1.0, p  0.65); mitochondria
bnormalities including changes in number, size, shape
nd cristae appearance (1.2  0.5 vs. 1.2  0.8, p  1.0);
nd dilation of sarcotubular elements (1.6  0.5 vs. 1.0 
.8, p  0.18) were all comparable before and after
VAD unloading. The rest of the ultrastructural param-
ters included in our electron microscopy classification
cheme (described in the Online Appendix) were also
ound to be similar before and after LVAD unloading. In
greement with these findings, the cardiomyocyte glycogen
ontent, as assessed by digital microscopy, was unchanged
etween pre- and post-LVAD unloading (Fig. 7B). Also,
here was no difference between ischemic and nonischemic
hronic HF patients.
Figure 3 Microvascular Density
Plots represent mean  SEM. LVAD  left ventricular assist device.
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July 27, 2010:382–91 Unloading, Microvasculature, and Cardiac Remodelingiscussion
his study demonstrates that pulsatile mechanical unload-
ng of the failing heart increases microvascular density. In
Figure 4 Endothelial Cell Activation
Ultrastructural appearance (10,000 magnification, Patient #2) of capillaries before a
thelial cell activation after LVAD. (A) Before LVAD. Short red arrows  basal lamin
(B) After LVAD. Short red arrows  basal lamina reduplication; blue arrows  increas
irregular lumenal surface (long red arrow). (C) After LVAD. Basal lamina reduplication
protruding into the capillary lumen (black arrows); and numerous irregular lumenal an
Figure 5 Microvascular Lumenal Area
Plots represent mean  SEM. LVAD  left ventricular assist device.tgreement with this finding, we found ultrastructural and
mmunohistochemical evidence of post-LVAD endothelial
ell activation. The decrease of the microvascular lumenal
rea observed by ultrastructural electron microscopy was
onfirmed by structural digital microscopy. The vascular
hanges were accompanied by increased fibrosis and reduced
ardiomyocyte hypertrophy without any structural, ultra-
tructural, or metabolic evidence of outright degeneration
nd atrophy. To our knowledge, this is the first study that
xamines the direct effects of unloading on myocardial
icrovasculature and endothelium and simultaneously cor-
elates the effects of LVAD unloading on microvasculature,
brosis, and hypertrophy. Furthermore, the adoption of
hole-field digital histopathology (9,10) allows comprehen-
ive endocardium-to-epicardium examination and avoids
ias intrinsic to the selection of random fields, the chief
eans of analysis used in previous studies.
echanistic links among microvasculature, fibrosis, and
ypertrophy. A large body of work has shown that endo-
r left ventricular assist device (LVAD) unloading revealed strong evidence of endo-
e arrows  cytoplasmic organelles and nuclei; long red arrow  capillary lumen.
clei size and increased cytoplasm organelles protruding into the capillary lumen—
rrows); increased nuclei and cytoplasmic size with increased pinocytotic vesicles
ce membrane projections (blue arrows); all indicative of endothelial activation.nd afte
a; blu
ed nu
(red a
d surfahelial and epithelial cells can transition to fibroblast or
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Unloading, Microvasculature, and Cardiac Remodeling July 27, 2010:382–91esenchymal phenotypes and through this endothelial-to-
esenchymal transition contribute to fibrosis of many
issues (7,13). In a recent seminal article that used lineage
racing in a mouse model of aortic banding, Zeisberg et
l. (7) showed that cardiac fibrosis was directly related to
ndothelial cells as those were activated and adopted a
Figure 6 Cardiac Fibrosis
(A) Normal donor heart; (B) before left ventricular assist device (LVAD); (C) after
63 days of LVAD-induced unloading (Patient #2); 20 magnification; (D) interstitia
Figure 7 Cardiomyocyte Studies
(A) Cardiomyocyte size evaluation; (B) cardiomyocyte glycogen stores evaluation.esenchymal or fibroblastic phenotype via pathways
irectly implicated in maladaptive cardiac hypertrophy.
hese findings were widely perceived in both the basic
nd clinical research arenas as the establishment of a
ignificant pathophysiological link among myocardial
icrovasculature, fibrosis, and hypertrophy (8). Other
increased fibrosis (Masson’s stain–collagen content stains blue) after
sis and total fibrosis—see text for definitions. Plots represent mean  SEM.
epresent mean  SEM. LVAD  left ventricular assist device.LVAD:
l fibroPlots r
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July 27, 2010:382–91 Unloading, Microvasculature, and Cardiac Remodelingrogenitor cells that could serve as fibroblast precursors
nclude pericytes, fibrocytes derived from bone marrow,
nd myofibroblasts (alpha-smooth muscle actin-containing
ontractile cells). With regard to the latter, alpha-smooth
uscle actin immunostaining was very rarely identified in
ells other than contractile cells of the vessel walls and was
ot different between our pre- and post-LVAD samples
data not shown).
Our study of human patients revealed post-LVAD in-
rease in microvascular density, a finding that is in agree-
ent with experimental data of unloading by means of
eterotopic transplantation (14). Our ultrastructural analysis
rovided mechanistic insights by revealing strong evidence
f post-LVAD endothelial cell activation. Previous animal
odels of angiogenesis in myocardial and skeletal muscle
evealed that ultrastructural endothelial cell activation rep-
esents 1 of the early stages of capillary growth and
rteriogenesis (12,15). Furthermore, the increased micro-
ascular density we identified was accompanied by increased
brosis, and this suggests that the mechanistic link between
he endothelium and cardiac fibrosis might apply to human
yocardium. Obviously, direct proof for such a mechanism
equires sophisticated lineage tracing possible only in genet-
cally manipulated animal models (7,8). Of note, work done
n our laboratory has increasingly shown that endothelial
roliferation and migration, hallmarks of angiogenesis, must
e balanced by mechanisms that stabilize the endothelium,
o that a functional vascular network might be established
nd maintained (16–18). The findings of this study suggest
n imbalance in these competing signals after LVAD
mplantation (19), which possibly results in increased mi-
rovascular density and endothelial activation that might
ontribute to cardiac fibrosis.
linical research implications. Future studies need to
ddress not only the association of increased microvascular
ensity, endothelial activation, and cardiac fibrosis but must
lso identify the primary triggers. One possibility is that the
yocardial microvessel growth is stimulated by mechanical
nd hemodynamic factors associated with increased blood
ow (20). However, although cardiac output is increased by
VAD (as also found in our study), previous positron
mission tomography studies have shown that this is not
ccompanied by increased coronary flow (21,22). Of note, in
Harefield group study, even though all subjects showed
arying degrees of LVAD-induced myocardial recovery,
ost-LVAD coronary flow reserve was impressively im-
aired, and the authors concluded that this finding required
urther investigation (21). This latter finding could be
xplained by the decreased microvasculature lumen area
ound in our study by both whole-field digital microscopy at
he structural level and by electron microscopy at the
ltrastructural level.
Whether LVAD unloading results in increase or decrease
n fibrosis is controversial (2,3,5,6,23). The reasons for
iffering findings in various studies are unclear but might be
elated to the methodology used (2,3,5,23). Our use of oigital histopathology (9,10) enabled us to examine the
hole field from endocardium to epicardium, which signif-
cantly reduced any selection or observer bias and removed
he confounding effect of endocardial or epicardial sam-
ling, known to be associated with different degrees of
brosis (24). In addition, our results were derived from a
otal myocardial analysis area that greatly exceeds that of
revious reports (2,5). Recently published human data
emonstrated increase in post-LVAD cardiac content of
ngiotensin I, angiotensin II, and norepinephrine (6,25),
ndings compatible with the increased fibrosis observed in
ur study. Furthermore, experimental studies of heterotopic
ransplant also showed unloading-induced increase in myo-
ardial fibrosis (26,27).
The hypertrophy regression observed in our study is in
greement with experimental heterotopic transplantation
ata (14,26,27) and also with other studies in humans
howing that LVAD unloading reversed the altered cardiac
xpression and function of natriuretic peptides and receptors
long with parallel reductions in myocardial mass and
yocyte size (3). However, whether the hypertrophy of
uman failing hearts unloaded by means of LVAD regresses
o the point of atrophy and degeneration is controversial and
equires further investigation (2,3,5). In our study of failing
uman hearts, the absence of post-LVAD cardiomyocyte
trophy and degeneration was not based only on cardiomy-
cyte size data but was reinforced both by ultrastructural
lectron microscopy findings and by metabolic findings.
iven that atrophy has been associated with significantly
ncreased glycogen concentration (28,29), the lack of change
f glycogen content after LVAD unloading observed in our
tudy (with a trend to decrease) does not seem to be
ompatible with LVAD-induced cardiac atrophy. To our
nowledge the question of LVAD-induced atrophy and
egeneration has not been specifically addressed by previous
VAD clinical studies on ultrastructure or quantitative
etabolic changes, and from this perspective our study adds
o the published data.
tudy limitations. A number of limitations of our study
eed to be addressed in future investigations. First, to focus
n the role of mechanical unloading on the failing heart,
rugs that are hypothesized to have direct effects on remod-
ling would not be employed or their use would be random-
zed. However, we do note that only 2 of our patients were
reated with such medications, and their results were not
ignificantly different from patients not given any such
edications. Second, the post-LVAD decrease of myocyte
ize might have possibly affected other morphometric mea-
urements that are based on the relative representation of
ther myocardial constituents. However, the structural
hanges of the nonmyocyte myocardial constituents in our
tudy were of such magnitude that even demonstration of
elative increases could potentially have significant func-
ional myocardial consequences. While the variable duration
f mechanical support is another limitation of our study, it
ffers advantages as well, given that investigating the effects
o
w
s
L
r
o
t
1
i
m
r
w
L
d
p
t
b
p
i
p
t
f
g
C
T
h
n
n
p
T
a
h
A
T
U
i
D
t
A
H
(
R
R
G
8
a
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
390 Drakos et al. JACC Vol. 56, No. 5, 2010
Unloading, Microvasculature, and Cardiac Remodeling July 27, 2010:382–91f LV unloading as a function of time is important and not
ell-studied (27). We found that the tissue changes were
imilar in all the patients despite differences in duration of
V unloading. Moreover, it is possible that reactive fibrous
esponse could have been present in myocardial tissue
btained at LVAD explantation, even though in an attempt
o avoid this phenomenon we obtained our samples at least
cm from the LVAD inflow cannula. We believe that this
s not very likely, however, because we verified that no
orphologic findings suggestive of reactive inflammatory
esponse were present in the studied myocardium. Finally,
e studied the effects of unloading induced by pulsatile
VAD, and this can be perceived as a limitation, because—
ue to mainly engineering reasons—continuous flow, non-
ulsatile devices are increasingly used. However, whether
he prospect of LVAD-induced reverse remodeling is
etter-served by pulsatile (30–32), nonpulsatile, or counter-
ulsation (3,33) devices or by full versus partial (34) unload-
ng is unknown. Consequently, understanding the effects of
ulsatile devices on remodeling becomes extremely impor-
ant as the field is evolving. Our findings might be useful for
uture comparative investigations of various types and de-
rees of mechanical unloading.
onclusions
he LVAD-induced unloading of the failing human
eart increased microvascular density and was accompa-
ied by endothelial cell activation, increased fibrosis, and
o structural, ultrastructural, or metabolic changes com-
atible with cardiomyocyte degeneration and atrophy.
hese clinical findings might guide future studies aimed
t unloading-induced reverse remodeling of the failing
uman heart.
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